Fourth, we did not include a control group of healthy individuals, because our main objective was to examine the associations between the plasma XOR activity and the risk of diabetic vascular complications and other metabolic disorders in patients with type 2 diabetes. The gene discussed is XDH; the disease is metabolic disease.